Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : SNY    save search

EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
Published: 2023-02-08 (Crawled : 00:00) - globenewswire.com
REGN | News S | $749.66 -2.63% -2.76% 530K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNYNF | News | $92.88 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

eylea treatment fda for approved injection
Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published: 2023-02-08 (Crawled : 16:00) - prnewswire.com
PFE | News 5 d | $43.98 0.9% 0.11% 15M twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 1.26% C: 0.99%
JNJ | News | $163.61 0.13% 0.27% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.97% H: 0.0% C: 0.0%
EBS | News | $13.25 -6.03% 3.89% 520K twitter stocktwits trandingview |
Health Technology
| | O: 2.6% H: 0.79% C: -5.29%
SNGX | News | $0.4601 2.2% -0.02% 34K twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 4.91% C: 2.27%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: 3.05% H: 0.0% C: 0.0%
NVAX | News | $10.44 -4.13% -4.31% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.8% H: 1.74% C: -4.13%
INO | News | $1.675 -9.95% -11.38% 4M twitter stocktwits trandingview |
Health Technology
| | O: -0.54% H: 2.73% C: -8.47%
BNTX | News | $141.15 -0.68% -0.66% 590K twitter stocktwits trandingview |
Health Technology
| | O: -0.54% H: 1.53% C: 0.68%

research global report for vaccine market
Retinal drugs market size to increase by USD 7.27579 billion; North America to account for 42% of market growth - Technavio
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
NVS | News | $86.89 0.64% 1.16% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.53% H: 0.0% C: 0.0%
ALC | News | $75.78 -0.13% 1.14% 500K twitter stocktwits trandingview |
Health Technology
| | O: 1.45% H: 0.21% C: -0.41%
ABBV | News | $144.61 -0.37% 0.27% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.38% H: 0.0% C: 0.0%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: 3.05% H: 0.0% C: 0.0%
MGTX | News | $7.74 -1.9% -1.81% 140K twitter stocktwits trandingview |
Health Technology
| | O: -3.11% H: 4.62% C: -0.77%

america for growth market
Dotmatics Scientific R&D Platform Introduces Built-in GraphPad Prism Integrations
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: 3.05% H: 0.0% C: 0.0%

prism platform
Innate Pharma to Participate in Upcoming Investor Conferences - February 07, 2023
Published: 2023-02-07 (Crawled : 10:00) - biospace.com/
NVO | News | $139.58 -0.01% 0.29% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: 1.64% H: 0.0% C: 0.0%

pharma
Smart Insulin Pens Market Size to Reach USD 302.1 Million in 2030 | Emergen Research
Published: 2023-02-06 (Crawled : 18:00) - prnewswire.com
NVO | News | $139.58 -0.01% 0.29% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.0% C: 0.0%
MDT | News F | $86.16 -0.49% 0.1% 4.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.08% C: -1.83%
LLY M | $340.73 0.31% 0.45% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: 2.75% H: 0.42% C: -1.26%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%

research smart insulin market
Silence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations Officer
Published: 2023-02-06 (Crawled : 14:00) - biospace.com/
SLN | News | $12.98 0.08% -0.23% 21K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 2.22% C: -0.84%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%

therapeutics
Concerto Biosciences Announces Strategic Business Development Hire
Published: 2023-02-06 (Crawled : 14:00) - biospace.com/
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%


Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Published: 2023-02-06 (Crawled : 14:00) - biospace.com/
SRRK | $11.94 -4.71% -5.21% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.93% C: -0.08%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%

commercial rock
Health Equity Report Card Pilot Project to Help Close the Care Gap Highlighted on World Cancer Day
Published: 2023-02-04 (Crawled : 16:20) - prnewswire.com
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNYNF | News | $92.88 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABBV | News | $144.61 -0.37% 0.27% 4.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

day care report health pilot cancer
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
Published: 2023-02-03 (Crawled : 16:00) - biospace.com/
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -4.01% H: 0.0% C: 0.0%

for trial sanofi
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Published: 2023-02-03 (Crawled : 12:00) - globenewswire.com
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -4.01% H: 0.0% C: 0.0%
REGN | News S | $749.66 -2.63% -2.76% 530K twitter stocktwits trandingview |
Health Technology
| | O: 2.47% H: 0.0% C: 0.0%
CTMX A | $2.6 -5.46% -5.57% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.13% H: 0.0% C: 0.0%
ACET | $8.21 -3.3% -3.35% 350K twitter stocktwits trandingview |
Health Technology
| | O: -1.34% H: 0.0% C: 0.0%

year financial results
Press Release : Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone
Published: 2023-02-03 (Crawled : 07:00) - globenewswire.com
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -4.01% H: 0.0% C: 0.0%

sales growth milestone
The Worldwide OTC Hyaluronic Acid Industry is Expected to Reach $6.2 Billion by 2027: Adoption of Nonsurgical Cosmetic Procedures Drives Growth
Published: 2023-02-02 (Crawled : 20:00) - prnewswire.com
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -4.01% H: 0.0% C: 0.0%

expected growth
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
TNXP | $1.23 4.24% 2.48% 4M twitter stocktwits trandingview |
Health Technology
| | O: -1.69% H: 0.0% C: 0.0%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 0.0% C: 0.0%
GILD | News M | $85.67 -0.44% -0.42% 5.9M twitter stocktwits trandingview |
Health Technology
| | O: -1.95% H: 0.16% C: -1.18%
VTRS | News | $11.92 -1.57% -1.59% 4.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 0.08% C: -0.41%
NVS | News | $86.89 0.64% 1.16% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.87% H: 0.01% C: -0.55%
JNJ | News | $163.61 0.13% 0.27% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.0% C: 0.0%
BMY | News S | $73.65 -1.17% 0.8% 7.9M twitter stocktwits trandingview |
Health Technology
| | O: -2.99% H: 3.64% C: 3.48%
ABBV | News | $144.61 -0.37% 0.27% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 0.0% C: -0.75%
VIR S | $27.07 -8.08% -8.79% 940K twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 2.22% C: 1.94%

global antiviral growth market
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
MRK S | $106.64 0.91% 0.22% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.83% H: 1.72% C: -0.54%
SGEN S | $136.89 -0.4% -0.49% 620K twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 1.07% C: 0.66%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 0.0% C: 0.0%
MRNA M | $164.34 -3.93% -4.09% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.82% H: 1.92% C: 1.7%

financial results
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 0.0% C: 0.0%
IGMS | $22.3 -5.31% -5.42% 80K twitter stocktwits trandingview |
Health Technology
| | O: 3.56% H: 6.95% C: 6.41%

conference
MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody® sonelokimab in moderate-to-severe hidradenitis suppurativa
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
MLTX | $14.7 5.0% 3.85% 44K twitter stocktwits trandingview |
| | O: 2.51% H: 1.71% C: -1.63%
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 0.0% C: 0.0%

nanobody trial
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
Published: 2023-02-02 (Crawled : 12:00) - globenewswire.com
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 0.0% C: 0.0%
BNTX | News | $141.15 -0.68% -0.66% 590K twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 1.63% C: 1.23%

dna
Frazier Life Sciences Adds Highly Experienced T Cell Immunologist to Team
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
SNY | News | $47.71 1.58% 1.57% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%

sciences life
Gainers vs Losers
57% 43%

Top 10 Gainers
CZOO | $0.2001 -16.63% 1874.01% 3.3M twitter stocktwits trandingview |

AVRO | $1.69 93.7% 54.08% 38M twitter stocktwits trandingview |
Health Technology

CELZ | $1.04 101.04% 50.26% 140M twitter stocktwits trandingview |

WETG | $0.65 58.54% 37.88% 27M twitter stocktwits trandingview |

GFAI | $0.5408 58.36% 36.88% 89M twitter stocktwits trandingview |

KPRX | $6.94 52.53% 34.15% 36M twitter stocktwits trandingview |
Manufacturing

PRFX | $0.7236 44.72% 30.07% 14M twitter stocktwits trandingview |
Health Technology

BJDX | $0.64 37.16% 23.51% 2.8M twitter stocktwits trandingview |

SOUN 4 | $4.63 28.61% 22.08% 62M twitter stocktwits trandingview |

THCH | News | $5.3 26.19% 19.69% 750K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.